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The following case was presented at Medical Grand Rounds at the Yale-New
Haven Hospital and theYale School ofMedicine by Stephen J. Huot, Assistant
Professor ofMedicine (Nephrology) with accompanying discussion ofdiagnos-
tic ultrasound studies by Dr. Leslie Scoutt, Associate Professor of Diagnostic
Radiology, and discussion of surgical management by Dr. George Meier,
Associate Professor ofSurgery.
INTRODUCTION
Dr Stephen J. Huot:
The clinical features, natural history, diagnosis and managementofrenal artery steno-
sis in patients with hypertension and renal insufficiency will be illustrated by discussion
of a patient evaluated at the Yale Vascular Center. Dr. Leslie Scoutt, Department of
Diagnostic Imaging, will discuss the utility of renal doppler ultrasound studies for diag-
nosing renal artery stenosis and review the findings in this patient. Dr. George Meier,
Department ofSurgery, will discuss surgical approachs and management ofpatients with
complex vascular disease manifested by renal artery stenosis and renal insufficiency.
CASE PRESENTATION
The patient is a 72 year old white woman who presented in July 1995 with refracto-
ry hypertension and progressive renal insufficiency. Her clinical course is outlined in
Figure 1. She was first diagnosed with high blood pressure in 1970 which had been suc-
cessfully controlled with medication until September 1994. At that time, her blood pres-
sure became poorly controlled, requiring several changes in her medications. Her blood
pressure remained elevated despite these changes. She stated that she was compliant with
her medications, was not taking any over-the-counter drugs such as non-steroidal anti-
inflammatory agents ordecongestants, and thatherweighthad been stable with no change
in her physical activity level.
In January 1995, four months after the documented worsening ofblood pressure con-
trol, the patient was admitted to her local hospital in New York with unstable angina and
ruled in for a non-Q-wave myocardial infarction. Echocardiogram revealed anterior and
inferior hypokinesis with an estimated ejection fraction of 38 percent. There was both tri-
cuspid andmitral regurgitation. On the second hospital day, despite treatment with aspirin,
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intravenous nitroglycerin and intravenous heparin, she developed recurrent chest pain
with anterior-lateral electrocardiogram changes and was transferred to Yale-New Haven
Hospital (YNHH) for cardiac catheterization. Upon arrival at YNHH, the patient was
noted to have renal insufficiency with a blood urea nitrogen (BUN) of 38 mg/dl and a
serum creatinine of3.0 mg/dl. She was also found to have congestive heart failure which
was successfully treated with diuretic agents.
A cardiac angiogramperformed on the third hospital day revealed an ulcerated, prox-
imal stenosis of90 percentinvolving the left anteriordescending coronary artery. The fol-
lowing day she underwent angioplasty of this lesion and placement of a Palmaz-Schatz
stent. She did well clinically with respect to her cardiac disease with no recurrent chest
pain or congestive heart failure.
Review of her medical records documented a serum creatinine in April 1994 of 1.4
mg/dl. When admitted to the hospital in New York in January 1995, her BUN and creati-
nine were 37 mg/dl and 2.8 mg/dl, respectively, which was attributed to pre-renal
azotemia. Following cardiac catheterization her serum creatinine transiently peaked at 3.8
mg/dl, and decreased to 3.2 mg/dl by the time ofdischarge. Evaluation ofher renal insuf-
ficiency included urinalyses that were negative forprotein, a 24 hour urine collection with
a calculated creatinine clearance of 35 ml/min, and a renal ultrasound examination which
showed no hydronephrosis, increased echogenicity bilaterally and preserved kidney size
(right kidney 10.1 cm, left kidney 12.6 cm). The transient increase in serum creatinine
during this hospitalization was attributed to dye-induced acute tubular necrosis (ATN)
associated with her catheterization. The etiology ofherelevated creatinine prior to admis-
sion, however, was not clear.
The patient was discharged on January 24, 1995 and went home in stable condition
with local follow-up in New York. Medications at discharge were dipyridamole, 75 mg
three times daily; enteric coated aspirin, 325 mg once daily; warfarin, 2.5 mg daily; dox-
azosin, 5 mg daily; labetalol, 400 mg twice daily; cardidopa-levodopa, 50/200 and 25/100
each once daily; amantadine, 100 mg daily; selegiline, 2.5 mg daily; and prednisone, 7.5
mg daily. One month after discharge her coumadin and persantine were discontinued as
planned.
InApril 1995, two months after coronary angioplasty, the patient noticed bluish, mot-
tled appearing lesions on her toes and feet bilaterally. She developed pitting edema that
extended from her ankles to her thighs. Despite the addition of furosemide, 40 mg daily,
the lesions and edemapersisted. She was then referred to theYaleVascular Center in June
1995. Pulse volume recordings of the lower extremities demonstrated adequate large ves-
sel flow and the etiology of her lesions was believed to be embolic. Evaluation for focal
cardiac or aortic sources ofembolization with transesophageal echocardiogram and mag-
netic resonance imaging ofthe chest and abdomen were negative, although diffuse ather-
osclerotic disease was documented. Her blood pressure at this time was 190/114 mm Hg
and her serum creatinine was 3.8 mg/dl. Because ofher refractory hypertension and renal
insufficiency, the diagnosis ofrenal artery stenosis was entertained. An evaluation was ini-
tiated that included a 24 h urine collection to quantify renal function and proteinuria, sero-
logic and additional urine studies to rule out primary renal disease and a captopril renal
scan (CRS), measuring renal uptake of radiolabled captopril, as an initial evaluation for
renal artery stenosis (RAS). Her furosemide and labetalol doses were increased to address
her poor blood pressure control, and the patient was scheduled to return for follow-up.
She returned to theVascular Center onAugust4, 1995 reporting anorexia, fatigue and
nausea. Her blood pressure was improved but still elevated at 178/100 mm Hg. Her sero-
logic studies were unrevealing for any primary renal disease, such as lupus nephritis, vas-
culitis, etc. Hercaptopril renal scan showed no isotope uptake by the rightkidney and nor-
mal perfusion and normal time to peak isotope activity in the left kidney. The report was
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consistent with non-functioning right kidney and no scintigraphic evidence ofrenal artery
stenosis on the left. Follow-up blood work obtained at this visit revealed significant wors-
ening ofrenal function. BUN and creatinine were 102 mg/dl/ and 5.8 mg/dl, respectively.
Calculated creatinine clearance was only 8 ml/min and 24 h urinary protein excretion was
580 mg. Despite the negative CRS, renal artery stenosis was still considered a possible
diagnosis for this patient because ofthe her clinical course.
The patient was therefore admitted toYNHH for treatment of worsening renal func-
tion, hypertension management and further evaluation forpossible renal artery stenosis or
other etiology ofprogressive renal failure with atheroembolic disease being ofsignificant
concern.
Her past medical history included Parkinson's disease for seven years with good
symptom control and polymyalgia rheumatica for one year treated with prednisone, 2.5
mg daily. She had a twenty pack-year smoking history but stopped smoking thirty years
ago, did not drink alcohol and had retired from pediatric nursing two years earlier. She
denied any history of elevated cholesterol, or diabetes, or family history of cardiovascu-
lar, cerebrovascular, or renal disease.
On physical examination, the blood pressure was 178/100 mm Hg lying down with a
pulse of 60 beats per minute. The fundoscopic exam showed no exudate, hemorrhage or
papilledema. There was nojugular venous distention. The lungs were clear. There was a
normal SI and S2 on cardiac exam with agrade IIIVI systolic murmurheard along the left
lower sternal border. There was no pericardial rub. The abdomen had normal bowel
sounds, no organomegaly and no anterior abdominal or flank bruits. Examination of the
extremeties revealed bilateral 1-plus ankle edema, warm feetwith goodcapillary refill and
a mottled bluish hue to all toes. There were several small necrotic lesions on three ofthe
toes distally. Vascular exam revealed intact pulses throughout with no bruits. Neurologic
exam was notable for a slight intention tremor ofthe hands and a slight slowing ofspeech
but otherwise was nonfocal.
SCr (mg/dl) - 3 3.8 5.8
BP (mm/Hg) 180/100 168/90 - 190/114 178/100
Peripheral
Unstable emboli, Evaluation Anorexia,
Diagnosed angina. peripheral foremboli, fatigue,
with high Angioplasty/ edema. CRS, 240 nausea,
blood BP meds stent. Renal Furosemide urine, admitted
pressure changed ultrasound added serologies to Y-NHH
I tI I I I I
1970 9/94 1/95 4/95 6/95 8/95
SCr = Serum Creatnine
BP = Blood Pressure
Figure 1. Clinical course ofthe patient.
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DISCUSSION
In summary, our patient is a 72 year old woman with long-standing hypertension that
over the preceding nine months became difficult to control. This occurred during a time
when she developed progressive renal failure, coronary artery disease requiring angio-
plasty and stent placement, and embolic arterial disease of the lower extremities.
Evaluation for primary renal disease showed no evidence of this. Captopril renal scan
showed non-function of the right kidney and no scintigraphic evidence of renal artery
stenosis on the left. A renal ultrasound examination done in January 1995 documented
echogenic kidneys, no hydronephrosis and preserved renal size. Creatinine clearance was
now only 8 ml/minute and the patient would likely require chronic dialysis in the near
future unless a reversible process could be identified and treated.
Our two leading diagnoses were 1) renal artery stenosis causing renovascular hyper-
tension (RVH) and renal failure due to ischemia, or 2) renal failure due to atheroembolic
disease ofthe kidneys with subsequent exacerbation ofhypertension. There were several
important clinical questions that needed to be addressed to determine the most appropri-
ate way to evaluate this patient. These were (a) given the likely etiology ofher worsening
renal function and refractory hypertension, is the process reversible? (b) what is the safest
diagnostic approach to determine ifthis patient has renal artery stenosis given her degree
of renal insufficiency, history of embolic disease, and co-morbid illness? and (c) if a
stenotic lesion is identified that could be surgically approached, what is the likelihood of
improvement in renal function and/or blood pressure control and what revascularization
procedure would be most appropriate?
Relevant to answering these questions is an understanding of the prevalence, natural
history, and clinical characteristics ofpatients with RAS and RVH.
Prevalence. Data from autopsy series, studies ofpatients undergoing aortograms, and
studies of patients referred for cardiac catheterization show a prevalence of RAS that
ranges from 29 percent to 60percent. None ofthese represent an "unselected" patientpop-
ulation and therefore undoubtedly overestimate the prevalence ofRAS in the general pop-
ulation. Interestingly, the prevalence of bilateral disease among patients with renal artery
stenosis is quite high as illustrated in Table 1. The incidence of bilateral disease reported
in the 5 studies presented in this table range from 27 percent to 66 percent ofpatients with
arteriographically documented RAS [1-8].
Table 1. Natural history ofatherosclerotic renovascular disease: reportsofserialangiogam [5]
Reference Months Number Percent with t Percent with
of follow-up progression total occlusiont
Wollenweber 1968 12-88 30 70 NA
Meaney 1968 6-120 39 36 8
Dean 1981 6-102 35 29 11
Schreiber 1984 12- >60 85 44 16
Tollefson 1991 15-180 48 71 15
Total 237 49 14
t Progression ofdisease includes worsening ofalready stenosed renal artery ordevelopment ofcon-
tralateral renal artery stenosis; t Total occlusion of a single stenosed renal artery. NA = Not
Available.
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Natural History. A small number ofstudies have looked at the natural history ofrenal
artery stenosis. Two of the most important ones are summarized here. In 1981, Dean and
colleagues reported the results of a prospective study in which patients with "surgically
correctable" RAS were randomized to receive either medical or surgical therapy for treat-
ment of hypertension (Table 1) [6]. Forty-one patients were randomized to the medical
treatment group. Thirty five ofthese 41 had a follow-up angiogram from 6 to 102 months
after initial screening (mean, 28 months). Twelve percent progressed to complete occlu-
sion of the original lesion by 12 months and another 17 percent developed contralateral
stenosis. Blood pressure control did not correlate with likelihood of progression.
Morbidity and overall mortality were not reported and no comparison was made with the
group randomized to surgery.
In 1984 Schreiber and colleagues reported a retrospective study which included 85
hypertensive patients with atherosclerotic RAS who had follow-up arteriograms from 6 to
84 months after their initial study [7]. Thirty seven ofthe 85 patients (44 percent) showed
progression of the original lesion including 14 (16 percent of patients overall) who pro-
gressed to total occlusion. Progression to occlusion occurred more frequently and more
rapidly in patients with a greater degree of stenosis at baseline. As in the Dean study,
blood pressure control did not correlate with progression and only 54 percent of the
patients with occlusion had an increase in serum creatinine. Of note, 70 percent of the
patients with progression had a decrease in renal size. Decrease in renal size has also been
reported in a number of other studies to correlate with progression of renal artery steno-
SiS.
Clinical Characteristics. The clinical characteristics associated with RAS are
advanced age, history of tobacco use, and documented vascular disease such as a history
of claudication or angina, or presence of a bruit on physical examination. Documented
vascular disease is the clinical characteristic that correlates most closely with presence of
RAS. It does not, however, predict functional status of a stenosis. Racial differences in
prevalence ofRAS are controversial. Early studies reported a very low prevalence ofRAS
and RVH in black hypertensive patients. However, more recent studies refute this premise.
For example, a study reported by Svetky et al. in 1991 used arteriograms to evaluate sixty
seven black and ninety seven white hypertensive patients with clinical characteristics con-
sistent with the possible diagnosis of RAS [9]. Twenty-seven percent of the white hyper-
tensives and 20 percent of the black hypertensives had RAS (no significant difference).
Halfof the patients in each group had RVH in that blood pressure control improved with
revascularization. Additional studies have reported similar results. Therefore, although
RAS may be slightly more prevalent in white hypertensives, it is also common in black
hypertensives.
The patient we are discussing today had advanced age, history of tobacco use, and
documented vascular disease. We thought it likely that she had renal artery stenosis and
possibly renovascular hypertension. Given the prevalence and natural history ofRAS, we
also thought it possible that she had developed bilateral disease and that this was the cause
of her deterioration in renal function.
Diagnosis. There are two categories of diagnostic tests available to help determine
whether or not patients have RAS and RVH. These include functional studies and a vari-
ety ofimaging modalities (Table 2).
Of the functional studies, plasma renin assays vary significantly with sodium intake,
volume status, cardiac output and even position. Blood pressure response to pharmaco-
logic agents such as angiotensin-converting enzyme inhibitors is dependent on volume
status and co-morbid conditions and is also not reliable [3, 10]. CRSs are commonly used
atYNHH and will be discussed in greater detail.
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Table 2. Diagnostic tests for renal artery stenosis
FUNCTIONAL STUDIES
Captopril Renal Scans
Plasma Renin Assay
Blood Pressure Response to Pharmacologic Agents
IMAGING MODALITIES
Arteriography
Digital Subtraction Arteriography
Magnetic Resonance Arteriography
CO2 Arteriography
Doppler Ultrasound
Spiral CT
CRS were initially validated in patients over age 55 with poorly controlled or refrac-
tory hypertension who had a history oftobacco use and evidence ofvascular disease [ 1].
In this group, the test was 91 percent sensitive and 94 percent specific for identifying
patients with atherosclerotic RAS. In addition, the presence ofcaptopril-induced changes
on the renal scan correlated with a high likelihood of improved blood pressure response
to revascularization (15 of 18 patients revascularized improved). Patients who had RAS
and a negative CRS were less likely to respond to revascularization with an improvement
in blood pressure control (3 of 18 patients improved, p = .0004). The test is therefore often
used to identify patients with RAS who are most likely to benefit with improved blood
pressure following revascularization. However, the test has not been validated in nor-
motensive patients with renal insufficiency and it is less sensitive for identifying hyper-
tensive patients with RAS in the setting of bilateral renal artery stenosis, stenosis in
patients with a single functioning kidney, or in patients with severe renal insufficiency
[12].
These issues were of concern in the interpretation of our patient's study. She had
severe renal insufficiency and her CRS showed a nonfunctioning right kidney.
Physiologically this is equivalent to trying to identify stenosis in a patient with a solitary
kidney. Utility ofthe test in this setting is therefore limited. Given her presentation and the
presence of clinical characteristics consistent with RAS, we felt it likely that she had the
disease despite a negative CRS and decided to proceed with imaging studies. Choosing
the appropriate imaging study in this particular patient, however, was not straightforward
because ofher history ofartheroembolic disease, congestive heart failure, and renal insuf-
ficiency.
There are six imaging modalities available to visualize the renal arteries (Table 2).
Each has limitations and benefits. Conventional arteriography is considered the "gold
standard." Contrast induced nephropathy and atheroembolism from arterial puncture and
canulation of the renal arteries pose significant risks in patients with renal insufficiency
and diffuse vascular disease as was the case in our patient [3, 13, 14]. The presence of an
anatomic lesion on arteriogram also does not necessarily mean the patient has renovascu-
lar hypertension or that the stenosis is the cause of renal insufficiency if present. Our ini-
tial focus therefore was to try to rule out RAS with non-invasive or with less invasive
imaging procedures rather than proceed directly with a renal arteriogram.
With intravenous digital subtraction angiography, computer enhancement provides
an improved image of the renal arteries after injection of contrast. While avoiding
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manipulation of the aorta and renal arteries, the results are technically limited by obesi-
ty, movement, and presence of bowel gas and it still requires the administration of con-
trast dye. Intra-arterial digital subtraction angiography provides higher quality images
but offers minimal advantage over conventional arteriography in that it requires intra-
arterial injection of contrast, though often with a lower volume of dye [13, 15].
Magnetic resonance arteriography is an evolving technology that holds great promise
as a non-invasive arterial imaging technique [16]. Presently, respiratory artifact, peristal-
sis, tortuous vessels, calcification of ateromatous lesions, and turbulent flow are limiting
factors. The procedure is still experimental at many institutions and requires validation
with conventional arteriography. In addition, current magnetic resonance arteriography
does not provide high resolution imaging ofthe celiac axis and its branches which are fre-
quently used in revascularization procedures for patients with complex vascular disease.
This technique is also not sensitive for identifying stenoses in smaller accessory vesels or
in branch vessels.
Carbon dioxide arteriography has been developed as a non-contrast imaging alterna-
tive to conventional arteriography [17]. Advantages are that CO2 is nonallergenic, is not
nephrotoxic and is considerably less expensive than contrast dye. Presently, the technique
is limited in that it requires intra-arterial injection, has considerable variability in quality
due to bowel gas and peristalsis, and there is difficulty with the CO2injection systems. It
is an alternative for patients with known contrast dye allergy but is not suitable for routine
imaging ofpatients with suspected renal artery stenosis.
Doppler ultrasound is the imaging modality we chose to pursue initially. Although
current Doppler ultrasound technology has limitations, the procedure is non-invasive and
posses no risk to the patient. We reasoned that ifthe study were of high technical quality
and demonstrated patent renal arteries, we could avoid contrast administration. Also,
given the association ofdecreasing renal size with progression ofrenal artery stenosis, we
were interested in reassessing the current size of this patient's kidneys [15, 18].
Dr. Leslie Scoutt from the Diagnostic Imaging Department will address the use and
limitations of doppler ultrasound for diagnosing RAS and review the findings in this
patient.
Dr Leslie Scoutt:
As discussed by Dr. Huot, angiography remains the radiographic gold standard forthe
diagnosis of RAS. However, as also discussed, angiography is a suboptimal screening
modality, is expensive, invasive, potentially nephrotoxic, and there is risk of atheroemb-
lism.
Doppler ultrasound, a safe, noninvasive, and relatively inexpensive technique, pro-
vides both physiologic and anatomic data and has been explored since the 1980s as a
method of screening patients for RAS. Most ultrasound studies consider that an obstruct-
ing lesion must reduce the arterial diameter by > 60 percent to be hemodynamically sig-
nificant and diagnostic ofRAS. There are two techniques for diagnosing RAS by Doppler
ultrasound, both or which were applied to the patient we are discussing.
The first technique requires visualization ofthe entire main renal artery to search for
a focal area of increased peak systolic velocity (PSV) and post-stenotic turbulence at the
anatomic site of a stenosis. The second technique requires demonstration ofa decrease in
the rate of systolic acceleration within parenchymal renal arteries distal to a stenosis.
PSV increases focally at the anatomic site ofa hemodynamically significant stenosis.
Most authors consider a PSV > 180 cm/sec to be highly suggestive of RAS [19, 20]. As
noted above, to diagnose RAS by this ultrasound technique, post-stenotic turbulence
should be present as well. Because PSV can vary with cardiac output, the ratio of peak
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systolic velocity of the main renal artery is compared to peak systolic velocity of the
abdominal aorta (renal-aortic ratio: RAR). Studies have shown that an RAR > 3.5 has a
sensitivity of 84-91 percent and a specificity of 95-98 percent for the diagnosis of RAS
(Figure 2) [21-23].
Figure 2. (a) Doppler interrogation of the origin of the left renal artery reveals marked eleva-
tion ofpeak systolic velocity (PSV) > 350 cm/sec while (b) PSY in the aorta is 84 cm/sec yield-
ing an RAR of over 4. These findings are consistent with a high-grade renal artery stenosis of the
left main renal artery.
However, there are many limitations to this technique. The examination is technical-
ly difficult, requiring a great deal ofexpertise with examination times ofup to 1-2 h. Even
in expert hands, visualization of the entire main renal artery may be impossible in 30-40
percent ofpatients due to obesity, overlying bowel gas, and aortic calcifications. In addi-
tion, the course of the renal arteries is generally tortuous such that the angle of insonation
is often suboptimal (>60 percent) leading to overestimation of velocity. The deep loca-
tion of the renal arteries, transmitted cardiac/aortic pulsations, as well as respiratory vari-
ation may make Doppler sampling difficult. Furthermore, accessory renal arteries, which
may occur in 14-24 percent of patients, are rarely detected by color or pulse Doppler
examination [24]. Nor would it be likely that stenoses in smaller branch vessels could be
detected by this technique. In addition, inadvertent sampling of collateral vessels have
also resulted in false-negative examinations in patients with renal artery occlusions [21-
23].
The second Doppler ultrasound technique for diagnosing RAS involves measuring
the rate of systolic acceleration in renal parenchymal arteries which has been reported to
decrease distal to a hemodynamically significant stenosis. In fact, the decrease in systolic
acceleration becomes more pronounced as blood proceeds distal to the stenosis [25, 26].
Hence, the rate of systolic acceleration may be measured within the renal sinus or
parenchyma. Such measurements may be accomplished in virtually all patients, thereby
eliminating many of the technical as well as theoretical problems with the previously
described approach for diagnosing RAS. The explanation for this phenomenon is quite
complex and is, in part, attributable to a decrease in perfusion pressure distal to a hemo-
dynamically significant stenosis. Vessel compliance, peripheral resistance, vessel length
and diameter as well as the number of distal vessels all effect the rate of systolic acceler-
ation. In general, a decrease in vessel compliance will increase pulsatility or the rate of
systolic acceleration and attenuate potential tardus parvus effects (see below) caused by
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Figure 3. (a) Diagram ofthe wave form ofthe normal renal artery. The acceleration index (Al)
is the slope of the line in m/sec2 from the onset ofsystole to the early systole peak complex (ESP)
(arows). The acceleration time (AT) is the time in seconds from the onset of systole to the ESP.
(b) Normal parenchymal renal arterial waveform. There is continuous forward diastolic flow as
the normal renal vascular tree has a low peripherial vascular resistance. The normal RI should be
less than 0.7. Note the steep, almost vertical slope of the Al and short AT indicating a rapid rate of
systolic acceleration. (c) Diagram ofthe tardusparvus waveform. Note rounding and flattening of
the systolic peak. The AI is more horizontal, i.e. decreased, and the AT is prolonged. These findings
are indicative of a delay in the rate of systolic acceleration and are consistent with a hemodynami-
cally significant renal artery stenosis. (Reprinted with permission from Raven Press).
a.
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systolic acceleration and attenuate potential tardus parvus effects (see below) caused by
an upstream stenosis [25, 26].
The rate of systolic acceleration may be evaluated by calculating the acceleration
index, acceleration time, or by visual analysis ofthe renal artery waveform. Stavros et al.
[27] defined the acceleration index (Al) as the slope of the line from the onset of systole
to the early systolic peak complex (ESP) in meters per second squared and the accelera-
tion time (AT) as the time in seconds from the onset ofsystole to the ESP (Figure 3a). In
their study, anAI < 3.0 m/s2 was 85 percent accurate, 89 percent sensitive, and 83 percent
specific for diagnosing RAS (> 60 percent diameter reduction). AnAT >0.07 seconds had
an accuracy of 89 percent, sensitivity of 78 percent, and a specificity of 94 percent. An
abnormal waveform, defined as loss ofthe ESP orrounding/flattening ofthe systolic peak,
the so-called tardus parvus waveform, (Figure 3b) was even more reliable with an accu-
racy of 96 percent, a sensitivity of 95 percent, and a specificity of 97 percent (Figure 4).
This technique can be used to monitor the results of percutaneous transluminal angio-
plasty as well as surgical revascularization as the renal waveform should normalize fol-
lowing a successful procedure (Figure 4). Rene et al. [28] have reported that premedica-
tion with captopril makes this test more sensitive. Schwerk et al. [29] have also demon-
strated that the RI of intraparenchymal renal arteries will decrease in patients with mod-
erate to severe RAS.
While this Doppler technique can be adequately performed in almost all patients,
some theoretical issues remain unresolved. The technique is more sensitive for diagnos-
ing severe rather than moderate RAS [27, 28]. Lesions within branch vessels or accesso-
ry renal arteries may still be missed, although sampling in multiple areas within the kid-
ney (upper, middle and lower poles) will reduce this possibility. Nonetheless, collateral
blood flow around a high grade stenosis or occlusion may still obscure the diagnosis of
RAS [20]. More importantly, other systemic factors may affect the rate of systolic accel-
eration, making this test less sensitive and specific in certain patient populations. For
example, in children, a proximal lesion such as an abdominal co-arctation or aortic nar-
rowing due to William's syndrome may also cause a decrease in systolic acceleration,
thereby mimicking severe, bilateral RAS. Extrarenal factors such as aortic/mitral valvular
disease, left ventricular dysfunction, or even cardiovascular medications such as preload
p * _ S ~~~~~~~~~~~~~~~~~~MA
Figure 4. This patient had a high grade renal artery stenosis of the right renal artery. a) Note
rounding and flattening of the systolic peak, the so-called tardus parvus waveform. The RI is also
diminished at 0.47. b) Following successful surgical revascularization, the waveform has normal-
ized. (Reprinted with permission from Raven Press).
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and afterload reducers ormyocardial contractility agents might affect systolic acceleration
as well. Furthermore, arterial compliance decreases with age, hypertension, and diabetes.
A decrease in arterial compliance will increase pulsatility (i.e., the rate of systolic accel-
eration) and attenuate any tardus parvus effect derived from an upstream stenosis. Such
numerous, independent, criteria may explain why all authors have not found this tech-
nique to be equally as accurate in all populations [30].
To review thispatient'sfindings:
In January 1995 a renal ultrasound without Doppler examination demonstrated that
the right kidney measured 10.1 cm and the left kidney 12.6 cm. The 1.5 cm difference in
renal size is a borderline finding suggestive ofRAS on the right. A follow-up ultrasound
with Doppler examination in August 1995 revealed that the right kidney measured 10.0
cm, while the left kidney measured only 10.9 cm. The apparent decrease in size over 9
months is suggestive ofrenal vascular disease.
Doppler ultrasound examination ofthis patient was inconclusive by either of the two
techniques I have discussed. The left main renal artery could not be identified due to over-
lying bowel gas and there was some movement artifact due to her Parkinson's disease. No
flow was seen in the right renal artery, but the ultrasonographer could not definitively dis-
cern ifthis was areal finding or a technicalproblem.Analysis ofrenal parenchymal wave-
forms was also inconclusive. Mild flattening of the systolic peak was noted bilaterally,
more prominent on the right. However, these findings were notreproducible as the patient
hadtrouble holding herbreath and the waveform in the aortaalsolookedminimally abnor-
mal. The RI's (resistive indices) for both kidneys were 1.0 which is not consistent with
RAS (the RI is reported to be low or asymmetric in RAS) [29]. While this ultrasound
examination was not diagnostic of RAS, several features were suggestive of RAS which
could not be excluded on the basis ofthese findings. Given the high clinical suspicion of
disease and loss ofrenal length we felt that RAS was still high on the differential diagno-
sis for this patient and it was decided that another imaging modality would be required.
The ultrasound studies in this patient demonstrate several ofthe pitfalls of this tech-
nique as previously described; the examination is technically difficult, and physical char-
acters such as obesity, or as in this case, the inability to suspend respiration may make it
impossible to obtain adequate Doppler tracings from the main renal arteries. Although not
a discrete criterion, sonographers rely on the presence of asymmetry in Doppler tracings
(PSV, RI, and appearance ofwaveforms) as a diagnostic clue. Obviously, when disease is
bilateral one loses this ability. Furthermore, many systemic factors affect the rate ofaccel-
eration in the parenchymal renal arteries. In this case, decreased compliance due to age,
atherosclerosis and long standing hypertension with increased peripheral vascular resis-
tance, plus intrinsic medical renal disease (suggested by the abnormal RI of 1.0) might
have contributed to blunting ofthe decrease in systolic acceleration ortardusparvus effect
that one looks for with upstream bilateral stenoses.
Dr. Huot:
Given the clinical course, CRS, and ultrasound findings, we thought it possible that
this patient had occlusion of the right renal artery and severe stenosis of the left renal
artery. We therefore proceeded with an imaging modality that would provide adequate
anatomic information upon which to base a decision for revascularization. We chose to
obtain a spiral CT for this purpose. Dr. George Meier of the Department of Surgery will
address the use ofspiral CT for imaging renal arteries in patients with renal insufficiency
and complex vascular disease.
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Dr George Meier:
As has been stated, the imaging of renal artery stenoses has two complicating factors
which increase patient risk in the presence of renal insufficiency. First, all forms of iodi-
nated contrast media are nephrotoxic, increasing the likelihood of acute renal failure.
Second, in many patients with renovascular disease due to atherosclerosis, the aorta is
often quite degenerate, increasing the risk of atheroembolism and its associated morbidi-
ty. In fact, in this patient both issues were dominant: notonly did thepatienthave evidence
of severe renal dysfunction, she had previously suffered spontaneous atheroembolism to
her feet, presumably from an aortic source. Therefore, our initial efforts at diagnostic
imaging focused on lowering the risk ofimaging as much as possible, particularly relative
to the irreversible damage of atheroembolism. As you have heard described, this patient
underwent CRS and ultrasound before we decided to pursue more direct imaging of the
renal vessels. We chose spiral (also called "helical") computed tomography scanning (CT)
for this purpose.
Computed tomographic scanning has been widely available since the late 1970s and
is an accepted technique for diagnostic evaluation. Early CT was based on segmental data
sets, usually at 1 cm intervals. While this provided accurate cross-sectional reconstruc-
tions, the data were insufficient for saggital or 3-dimensional reconstruction. What was
necessary was a continuous data set over the area to bereconstructed, arequirement which
is technically solved by spiral CT scanning. In this technique, the patient moves continu-
ously through a scanner as it spins around his body. The helical slices can then be recon-
structed into axial, longitudinal, or 3-Dprojections. A refinement ofthis technique is com-
monly referred as CT angiography. In this technique intravenous contrast medium is
injected while the CT images are collected. The vessels can then be imaged in multiple
ways. Perhaps the most common vessel-imaging technique is the shaded surface display.
In this method, the surface of the intravenous contrast bolus is mapped and the interface
between contrast and the surrounding tissue is reconstructed in three dimensions. The
resultant image produces a luminal outline of the vessel in question, revealing stenoses
and aneurysms alike [31].
A second common technique for imaging the vessels in CT angiography is the max-
imum intensity projection. In this technique, a composite "look-through" image is recon-
structed. This image can be rotated in 3600 and is particularly helpful when calcium in
atherosclerotic plaque obscures luminal detail. In direct comparison using renal CT
angiography, maximum intensity projections seem to be more sensitive at detecting
stenoses than does shaded surface display [31].
The use of iodinated contrast medium is a requisite for conventional X-ray imaging
of blood flow. Nevertheless, its use in the absence ofarterial catheterization avoids poten-
tial atheroembolism as a complicating factor. This remains the fundamental advantage of
CT angiography: the lack of intra-arterial catheterization not only prevents catheter-
induced atheroembolism, it also allows the study to be virtually pain-free. The imaging
requires only a few minutes for data-set capture, after which the analysis is performed on
a post-processing workstation. Additionally, with three dimensional luminal reconstruc-
tion from the CT data set, anatomic details can be carefully defined and the area of steno-
sis can be evaluated fully.
In this patient, spiral CT angiography demonstrated bilateral disease, with diffuse
disease in the right renal artery and an ostial stenosis of the left. Given the recent docu-
mented decrease in left renal size by ultrasound, our focus for renal function salvage cen-
tered on the left kidney.
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Dr Huot:
We now knew that our patient had bilateral renal artery stenosis, documented
decrease in size ofher left kidney and renal failure that would require dialysis in the very
near future. In discussions with the patient and her family she stated a clearpreference for
revascularization over chronic dialysis. A cardiology assessment was obtained to deter-
mine cardiac surgical risk. The cardiologist's opinion following review of her clinical
course, an echocardiogram and a persantine-thallium stress test, was that while her risk of
perioperative myocardial infarction was increased due to her age and diffuse vascular dis-
ease, her cardiac function was stable and adequate to undergo surgical revascularization.
In consultation with the patient and her team ofphysicians it was decided to proceed with
surgical revascularization of the left kidney. Dr. Meier performed the surgery and he will
now address the selection of specific operative procedures in patients with complex vas-
cular disease, the potential benefits ofrevascularization forpreservation ofrenal function,
and the outcome in our patient.
Dr. Meier:
When confronted with new onset renal insufficiency in a patient with diffuse athero-
sclerotic disease, the challenges ofoperation are to minimize patientmorbidity while pro-
viding maximum benefit. In this case, renal salvage was the foremost indication for renal
revascularization. Given the risk of atheroembloism associated with angioplasty, particu-
larly in view ofthe extent of this patient's disease, surgical intervention was chosen.
The common traditional approach to renal revascularization is aortorenal bypass. In
this approach, the aorta is clamped, either partially or completely and a graft is placed
from the aorta to the renal artery. The main difficulty with this approach is the risk ofaor-
tic cross-clamping. When the aorta is cross-clamped, afterload rises precipitously; when
the aorta is unclamped, uncompensated hypotension can occur from the rapid afterload
reduction, inducing cardiac ischemia. Also, clamping of the aorta can induce atheroem-
bolism in patients such as this with diffuse atherosclerosis. For both reasons we wished to
avoid aortic cross-clamping and therefore decided to pursue an "extra-anatomic" bypass
procedure.
Extra-anatomic approaches to the renal artery were popularized in the mid-1980s and
remain a very attractive alternative for these patients. In this operation, the hepatic or
splenic artery is used for an inflow source for a graft to the renal artery. The fundamental
advantage in this procedure is avoidance of the hemodynamic and physiologic conse-
quences of aortic cross-clamping. This procedure is limited in patients with atherosclero-
sis ofthe celiac axis [32]. In this patient, the celiac axis had minimal disease and appeared
appropriate for renal revascularization. Since we were primarily interested in renal func-
tional salvage and not blood pressure control, we decided to revascularize the left kidnay
only and avoid the prolonged operative time that would be required to also revascularize
the right kidney.
A standard splenorenal bypass was done by direct anastomosis of the splenic artery
to the left renal artery (Figure 5). The spleen was not removed. Total operative time was
approximately 2 h. Post-operatively, the patient did quite well with an increase in urine
flow while still in the operating suite and subsequent improvement in renal function and
in blood pressure control.
Dr Huot:
As Dr. Meier stated, the patient did very well post operatively, both with regard to
blood pressure control and recovery of renal function. Her blood pressure was better
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controlled on one medication at discharge (amlodipine 2.5 mg once daily) than it had
been on four medications at the time of admission. Her creatinine at discharge was 2.3
mg/dl and has remained at this level as ofthree weeks ago.
For completeness, I would like to comment briefly on the role ofrenal angioplasty as
a revascularization alternative. Data on long term success ofrenal angioplasty are limited
and are confounded by recent changes in angioplasty technique, including the use of
stents. Angioplasty is the preferred technique for patients with fibromuscular disease
when technically feasible. For patients with atherosclerotic disease success of the proce-
dure is influenced by anatomic location and length of the stenosis. Angioplasty has been
most successful when used for short non-ostial lesions and is also an alternative for ostial
lesions with or without use of stents in patients with high surgical risk [33].
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Figure 5. Schematic drawing ofspleno-renal bypass.
SUMMARY
Renal artery stenosis has become increasingly common as a cause of refractory
hypertension and renal insufficiency. There is a high prevalence of bilateral disease and
the lesions tend to progress over time. Newer, less invasive, imaging modalities such as
doppler ultrasound, magnetic resonance angiography, and spiral CT scanning are evolv-
ing technologies in the diagnosis ofrenal artery stenosis. Advances in surgical technique,
particularly the development of extra-anatomical procedures such as spleno-renal and
hepato-renal bypass, have significantly lowered surgical morbidity and mortality and pro-
vides revascularization options forpatients with complex vascular disease that would pre-
viously not have been considered because of their high surgical risk. Improvements in
angioplasty technique and the use ofstents are broadening the types oflesions that can be
successfully approached with thesetechniques andmay beparticularly helpful forpatients
with more severe cardiac or cerebrovascular disease. The benefits of revascularization
may be even greater for preservation ofrenal function than for control of blood pressure
in properly selected patients.
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It is difficult to predict which patients will benefit from surgical revascularization ver-
sus medical management of RAS. Knowledge of the progressive nature ofRAS, the high
prevalence ofbilateral disease, and the clinical characteristics that correlate with progres-
sion (e.g., decreasing renal size) are helpful in guiding clinical decisions regarding inter-
vention. Additional studies to determine the predictive value of non-invasive tests such as
CRS, doppler ultrasound before and after administration of angiotensin converting
enzyme inhibitors, and other tests, are needed to assist the clinician in identifying who will
benefit most from revascularization both in terms of renal function and blood pressure
control.
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